NVLG: Novolog (Pharm-Up 1966) Ltd - Summary | Jitta

Novolog (Pharm-Up 1966) Ltd

ISR:NVLG

Price
₪0.92
Loss Chance
50.8%
3.17JITTA SCORE
154.56%Over Jitta Line
Jitta Ranking
316 / 421
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (26)
Recent Business Performance (28)
Financial Strength (52)
Return to Shareholders (34)
Competitive Advantage (41)
Jitta Signs
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 55.87% in the last year
Key Stats
Jitta Score
Jitta Line
3.17
154.56%
2.84
95.01%
Health Care Distributors
4.70
6.09%
COMPANY DESCRIPTION
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other medical services to patients, health organizations, insurance companies, multinational companies, and government bodies. The Digital division identifies and develops technological tools for health services; deals with making medical information accessible to the public through medical websites; promotes digital presence for clinics, doctors therapists, and medical bodies; provides services and management tools; and operates and markets digital platforms for doctors and clinics. In addition, the company provides appointment scheduling, calendar management, and telemedicine meeting management. Novolog (Pharm-Up 1966) Ltd was incorporated in 1966 and is headquartered in Modi'in-Maccabim-Re'ut, Israel.